NeuroBloc®/Myobloc®: Unique features and findings-Reference-Cited by-同舟云学术

NeuroBloc®/Myobloc®: Unique features and findings

Published:2009-10 Issue:5 Volume:54 Page:690-696
ISSN:0041-0101
Container-title:Toxicon
language:en
Short-container-title:Toxicon

Author:

Arezzo Joseph C.

Publisher

Elsevier BV

Subject

Toxicology

Reference27 articles.

1. Muscle fiber atrophy in leg muscles after botulinum toxin type A treatment of cervical dystonia;Ansved;Neurology,1997

2. Long-distance retrograde effects of botulinum neurotoxin;Antonucci;A. J. Neurosci.,2008

3. Spread of paralysis to nearby and distant non-injected muscles in a monkey hand model: Comparison of BoNT-A and BoNT-B;Arezzo,2002

4. Possible mechanisms for the effects of botulinum toxin on pain;Arezzo;Clin. J. Pain,2002

5. Birmingham, W., Pappert, E., Salazar-Grueso, E., 2008. Botulinum toxin Type B (Myobloc®) clinical safety in cervical dystonia following up to 4 years of treatment. Presented at the 2008 Annual Meeting of the American Academy of Neurology, Chicago.

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updated review on neuromodulators;Plastic and Aesthetic Research;2024

2. Review of Botulinum Toxin Uptake and Novel Theory Regarding Potential Spread Days After Injection;Aesthetic Surgery Journal;2023-02-27

3. An overview of the pharmacotherapeutics for dystonia: advances over the past decade;Expert Opinion on Pharmacotherapy;2022-11-22

4. Module 2: Nonsurgical management of Spasticity;The Journal of the International Society of Physical and Rehabilitation Medicine;2022

5. Complications and adverse effects of periocular aesthetic treatments;Survey of Ophthalmology;2021-04